Resultados de procura - Bruce Robinson

Limitar resultados
  1. 1
    Benign asbestos pleural effusion: diagnosis and course.

    Benign asbestos pleural effusion: diagnosis and course. por Bruce Robinson, Arthur W. Musk

    Publicado 1981
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Natural killer cells are present in the normal human lung but are functionally impotent.

    Natural killer cells are present in the normal human lung but are functionally impotent. por Bruce Robinson, P Pinkston, Ronald G. Crystal

    Publicado 1984
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment

    The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment por Delia J. Nelson, Scott Fisher, Bruce Robinson

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Risk of ESRD in the United States

    Risk of ESRD in the United States por Patrick Albertus, Hal Morgenstern, Bruce Robinson, Rajiv Saran

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

    Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. por Bruce Robinson, Theodore L. McLemore, Ronald G. Crystal

    Publicado 1985
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Authors’ Reply

    Authors’ Reply por Murilo Guedes, Bruce Robinson, Brian Bieber, Roberto Pecoits–Filho

    Publicado 2022
    Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  7. 7
    Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all

    Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all por Robbert van der Most, Andrew Currie, Bruce Robinson, Richard Lake

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Dialysis Outcomes and Practice Patterns Study (DOPPS)

    Dialysis Outcomes and Practice Patterns Study (DOPPS) por Bruce Robinson, Brian Bieber, Ronald L. Pisoni, Friedrich K. Port

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011

    The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011 por Douglas S. Fuller, Ronald L. Pisoni, Brian Bieber, Brenda W. Gillespie, Bruce Robinson

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.

    Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. por A Venet, A J Hance, Cesare Saltini, Bruce Robinson, Ronald G. Crystal

    Publicado 1985
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

    Programmed Death Ligand 2 in Cancer-Induced Immune Suppression por Esdy Rozali, Stanleyson V. Hato, Bruce Robinson, Richard Lake, W. Joost Lesterhuis

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Projecting ESRD Incidence and Prevalence in the United States through 2030

    Projecting ESRD Incidence and Prevalence in the United States through 2030 por Keith McCullough, Hal Morgenstern, Rajiv Saran, William H. Herman, Bruce Robinson

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011

    The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011 por Ronald L. Pisoni, Douglas S. Fuller, Brian Bieber, Brenda W. Gillespie, Bruce Robinson

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    The Testicular Effects of Tumor Necrosis Factor

    The Testicular Effects of Tumor Necrosis Factor por K. Mealy, Bruce Robinson, Clarke F. Millette, Joseph A. Majzoub, Douglas W. Wilmore

    Publicado 1990
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions

    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions por Furio Pacini, Yasuhiro Ito, Markus Luster, Fabián Pitoia, Bruce Robinson, Lori J. Wirth

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients

    Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients por Bruce Robinson, Marshall M. Joffe, Ronald L. Pisoni, Friedrich K. Port, Harold I. Feldman

    Publicado 2006
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives

    Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives por Murilo Guedes, Bruce Robinson, Gregorio T. Obrador, Allison Tong, Ronald L. Pisoni, Roberto Pecoits–Filho

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices

    Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices por Bruce Robinson, Tadao Akizawa, Kitty J. Jager, Peter G. Kerr, Rajiv Saran, Ronald L. Pisoni

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  19. 19
    Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time

    Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time por Bruce Robinson, Marshall M. Joffe, Jeffrey S. Berns, Ronald L. Pisoni, Friedrich K. Port, Harold I. Feldman

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice

    A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice por Wayne J. Aston, Danika E. Hope, Anna K. Nowak, Bruce Robinson, Richard Lake, W. Joost Lesterhuis

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: